At a glance
ClinicalIndex Comparison RecordN/ACompleted· 99 enrolled
Drug / intervention
Rituximab +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open, Noninterventional, Multicentre Trial of Rituximab in Combination With Chemotherapy (CVP, CHOP or FCM) Chemotherapy in Patients With Follicular Lymphoma
In Brief
An observational study evaluating Chemotherapy and Rituximab for Follicular Lymphoma. Completed, enrolled 99 participants across 6 sites.
Detailed Summary
The primary objective is to evaluate the safety profile and tolerability of rituximab in combination with different chemotherapy regimens.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFollicular Lymphoma
CountriesSerbia
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
Primary CompletionNov 2013
First PostedJun 2015
TodayJul 2026
First PostedJun 3, 2015
Enrollment StartApr 1, 2008
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 11.1 years ago
Interventions
Chemotherapyradiation
Rituximabdrug